These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34022371)

  • 21. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To Vaccinate or not to Vaccinate; That is the Question! (New Insights into COVID-19 Vaccination).
    El-Nakeep S
    Curr Mol Med; 2022; 22(7):567-571. PubMed ID: 33982651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. India's role in COVID-19 vaccine diplomacy.
    Sharun K; Dhama K
    J Travel Med; 2021 Oct; 28(7):. PubMed ID: 33870417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A values-driven approach to vaccine hesitancy conversations.
    North ZM; Smit AT; Jenkins LS
    S Afr Fam Pract (2004); 2022 Jan; 64(1):e1-e4. PubMed ID: 35144464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
    Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
    Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): A preliminary analysis from north India.
    Kaur U; Bala S; Ojha B; Jaiswal S; Kansal S; Chakrabarti SS
    J Med Virol; 2022 Jan; 94(1):407-412. PubMed ID: 34491572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Vaccine Uptake in Patients with Ocular Surface Diseases in India.
    Das AV; Goud R; Basu S
    Semin Ophthalmol; 2022 Feb; 37(2):193-194. PubMed ID: 34236941
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody responses to Sputnik Vaccination in naïve and COVID 19-recovered vaccine recipients, India.
    Sapkal G; Deshpande GR; Tilekar B; Yadav P; Abraham P; Salunke A; Patil C; Deshpande K; Patil R; Pawar N; Joshi A; Vaidya A; Shivankar A
    J Travel Med; 2022 May; 29(3):. PubMed ID: 35325194
    [No Abstract]   [Full Text] [Related]  

  • 30. The initial experience of COVID-19 vaccination from a tertiary care centre of India.
    Srivastava RK; Ish P; Covid-Vaccination Group S
    Monaldi Arch Chest Dis; 2021 Mar; 91(4):. PubMed ID: 33794595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trend in COVID-19 vaccination among people with diabetes: A short study from India.
    Nachimuthu S; Viswanathan V
    Diabetes Metab Syndr; 2021; 15(4):102190. PubMed ID: 34245963
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccination With Routine Childhood Vaccines and Severity of COVID-19 Among Children in Delhi.
    Majhi MM; Borle AL; Lal P; Meena M; Ramani KV
    Indian Pediatr; 2022 Feb; 59(2):132-134. PubMed ID: 34845990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
    Ameratunga R
    Expert Rev Vaccines; 2022 Sep; 21(9):1177-1184. PubMed ID: 35695410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
    Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
    EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rocky road to universal COVID-19 vaccination.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Jun; 21(6):743. PubMed ID: 34000242
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period.
    Bansal N; Raturi M
    Transfus Clin Biol; 2021 Aug; 28(3):310-312. PubMed ID: 33857620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.
    Levin J; Bradshaw M
    BMC Public Health; 2022 May; 22(1):1047. PubMed ID: 35614396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. India begins COVID-19 vaccination amid trial allegations.
    Bhuyan A
    Lancet; 2021 Jan; 397(10271):264. PubMed ID: 33485435
    [No Abstract]   [Full Text] [Related]  

  • 39. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India.
    Du Z; Wang L; Pandey A; Lim WW; Chinazzi M; Piontti APY; Lau EHY; Wu P; Malani A; Cobey S; Cowling BJ
    Nat Med; 2022 May; 28(5):934-938. PubMed ID: 35210596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study.
    Rodríguez-Blanco N; Montero-Navarro S; Botella-Rico JM; Felipe-Gómez AJ; Sánchez-Más J; Tuells J
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34063476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.